
MEDIVIR AB
Share · SE0020181014 · A3EFZT (XSTO)
No Price
n/a
Current Prices from MEDIVIR AB
Exchange | Ticker | Currency | Last Trade | Price | Daily Change |
---|---|---|---|---|---|
![]() London |
0GP7.L
|
SEK
|
25.02.2025 09:30
|
2,02 SEK
| 0,00 SEK |
Performance
Day | Week | Month | 3 Months | 6 Months | 1 Year | 5 Years |
---|---|---|---|---|---|---|
-1,74 % | -1,97 % | -2,12 % | -2,00 % | -28,83 % | -29,99 % | -81,33 % |
Company Profile for MEDIVIR AB Share
Medivir AB (publ) researches, develops, and sells pharmaceuticals primarily for the treatment of oncology in Sweden and internationally. The company markets Xerclear for the treatment of labial herpes under the Zoviduo name. It also develops Remetinostat for treating MF cutaneous T-cell lymphoma, as well as basal cell carcinoma. In addition, the company develops MIV-818 for the treatment of liver cancer; MIV-711 to treat osteoarthritis; and Birinapant and IGM-8444 for the treatment of solid tumors. It has a research collaboration with the Drug Discovery and Development Platform at SciLifeLab for the discovery of antivirals for SARS CoV-2; and a licensing agreement with the Tango Therapeutics for a preclinical research program, as well as Ubiquigent Limited for the preclinical research program USP7. Medivir AB (publ) was incorporated in 1987 and is based in Huddinge, Sweden.
Company Data
Name MEDIVIR AB
Company Medivir AB (publ)
Website
https://www.medivir.com
Primary Exchange
Frankfurt

WKN A3EFZT
ISIN SE0020181014
Asset Class Share
Sector Healthcare
Industry Medical - Pharmaceuticals
CEO Mr. Jens Lindberg
Market Capitalization 206 Mio
Country Sweden
Currency EUR
Employees 0,0 T
Address Lunastigen 5, Huddinge
IPO Date 2023-06-07
Ticker Symbols
Name | Symbol |
---|---|
Frankfurt | MVR0.F |
London | 0GP7.L |
More Shares
Investors who MEDIVIR AB hold also have the following shares in their portfolio:
The financial platform MoneyPeak tracks and analyzes investments and portfolios.
From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.